Author:
Fisara Petr,Guerino Frank
Abstract
Abstract
Background
The longer the duration of protection of an acaricide against canine infestation with Ixodes holocyclus, the lower the risk of gaps in tick control programs that will place dogs at risk of potentially fatal tick-induced paralysis. Two studies investigated the duration of efficacy provided by a novel injectable suspension of fluralaner (Bravecto QuantumTM) against this tick species.
Methods
In both studies, 20 clinically healthy dogs were randomized to an untreated control group or to a group treated once, on Day 0, with the injectable fluralaner suspension (15 mg/kg). Dogs were infested with up to 25 unfed adult female I. holocyclus ticks on Day -1, during Weeks 1 and 2, and then at intervals no greater than approximately 3 months for the 13 months following treatment. Ticks were assessed in situ at 24 and 48 h and assessed and removed at 72 h following treatment and each subsequent infestation. Efficacy was determined by comparing arithmetic mean live tick (attached or free) counts in the treated group with the control group.
Results
The untreated control dogs maintained adequate infestations for efficacy evaluations at all assessment weeks, with mean tick counts ranging from 16.2 to 21.6 in Study 1 and 14.0 to 23.5 in Study 2. The efficacy of fluralaner injectable suspension against existing infestations, determined 72 h following treatment administration, was 64.1% in Study 1 and 42.7% in Study 2. Efficacy against post-treatment infestations in Study 1 ranged from 95.7 to 100% from Week 1 through Week 57; in Study 2 efficacy was 100% at every assessment from Week 1 through Week 57. No treatment-related adverse events were recorded in either study.
Conclusion
The injectable fluralaner suspension was highly effective against I. holocyclus infestations of dogs from one week through 13 months following a single treatment. By placing treatment with the veterinarian, killing ticks within 72 h of attachment, and providing a full year of protection, fluralaner injectable suspension can help facilitate owner compliance with tick control treatment recommendations, thus reducing the risk of canine tick paralysis.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology,General Veterinary
Reference18 articles.
1. Padula AM, Leister EM, Webster RA. Tick paralysis in dogs and cats in Australia: treatment and prevention deliverables from 100 years of research. Aust Vet J. 2020;98:53–9.
2. Barker SC, Barker D. Ticks in Australia: endemics; exotics; which ticks bite humans? Microbiol Aust. 2018;39:194–9.
3. Teo EJM, Vial MN, Hailu S, Kelava S, Zalucki MP, Furlong MJ, et al. Climatic requirements of the eastern paralysis tick, Ixodes holocyclus, with a consideration of its possible geographic range up to 2090. Int J Parasitol. 2021;51:241–9.
4. Australian Government Department of Health and Aged Care. Paralysis from tick bites. 2022. https://www.health.gov.au/resources/publications/paralysis-from-tick-bites?language=en. Accessed 14 Feb 2023.
5. Barker D, Barker SC. Survey of cases of tick-paralysis and the presence of the eastern paralysis tick, Ixodes holocyclus, and the southern paralysis tick, Ixodes cornuatus, in the Greater Melbourne Area. Aust Vet J. 2020;98:2–10.